Nathan Vardi, Forbes Staff

Author's posts

This Legendary Billionaire Biotech Investor Has Remained A Mystery—Until Now

In an exclusive excerpt from For Blood And Money, the untold story of Wayne Rothbaum and the worst trade of his life. But what cost him some $700 million turned out to be the boon for countless cancer patients.

Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines Possible

Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines Possible

AstraZeneca’s Pascal Soriot Was The Hottest CEO In Pharma. Now He’s In The Hot Seat.

Pascal Soriot’s stunning corporate turnaround story at AstraZeneca is now mired in vaccine politics and doubt.

Pfizer CEO Albert Bourla Helped Save The World. Can He Save His Company’s Stock?

Delivering a game-changing vaccine was a sprint. Bourla says delivering returns for Pfizer shareholders is a marathon.

Moderna’s Mysterious Coronavirus Vaccine Delivery System

A preprint of preclinical data for Moderna’s coronavirus vaccine suggests it uses delivery technology that is covered by a patent owned by Arbutus and upheld last week.

AstraZeneca’s Calquence Showed Improvement In Small Group Of Hospitalized Covid-19 Patients

In a study of 19 sick Covid-19 patients, those who were on supplemental oxygen did better with the blood cancer drug than those on ventilators.

EXCLUSIVE: AstraZeneca’s Calquence Shows Early Promise For COVID-19 Patients

The blood cancer drug has been given to a small number of sick U.S. patients and massive clinical trials are being launched to determine its efficacy, as well as that of Imbruvica.